$6.89
▲ +1.1% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio (NUVB) Upgraded to Buy: Here's Why
Overview
52-week range
$2.99
$9.75
58% of range
Avg surprise (last 3)
-30.6%
Avg reaction (last 2)
-2.1%
0% positive
Latest IV / EM
90%
EM ±14.1% · $8 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.18 | — | — | — | — | financials |
| Mon May 4, 2026 | Mar/2026 | $0.01 | $0.12 | -91.7% | +106.2% | -1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.16 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.17 | $-0.17 | 0.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.16 | $-0.16 | 0.0% | — | -2.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.15 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.89 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.07 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.09 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.09 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.10 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32M | $83M | — | $13M | $5M | $3M | — | $727,000 |
| Cost of revenue | — | — | — | $3M | $3M | $2M | — | $2M |
| Gross profit | — | — | — | $10M | $2M | $990,000 | — | $-788,000 |
| Operating income | $-51M | $4M | — | $-56M | $-64M | $-59M | — | $-48M |
| Net income | $-63M | $5M | — | $-56M | $-59M | $-53M | — | $-41M |
| EPS (diluted) | $-0.18 | $0.01 | — | $-0.16 | $-0.17 | $-0.16 | — | $-0.15 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $259M | $125M | $164M | $99M | $248M | $48M | $36M | $30M |
| Inventory | $20M | $16M | $11M | $6M | $552,000 | $14,000 | $0 | — |
| Total current assets | $726M | $592M | $572M | $578M | $623M | $476M | $526M | $565M |
| Total assets | $745M | $610M | $595M | $602M | $647M | $492M | $541M | $572M |
| Long-term debt | $243M | $47M | — | $47M | $47M | — | — | — |
| Total liabilities | $491M | $291M | $289M | $276M | $274M | $73M | $77M | $69M |
| Total equity | $254M | $320M | $306M | $326M | $373M | $419M | $464M | $503M |